Clinical Trial Update: A Phase 1 Safety Study in Adults With Schizophrenia [Phase 1]

View source ↗

Summary

A Phase 1 safety study in adults with schizophrenia has completed, providing safety data from an Alkermes-sponsored trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Not disclosed

Snippet

Sponsor: Alkermes, Inc. | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED